COVID-19 mortality rate in children is U-shaped

Nina Khera1,2, Didac Santesmasses3, Csaba Kerepesi3

  • 1Buckingham Browne and Nichols School, Cambridge, MA 02138, USA.

Aging
|August 19, 2021
PubMed

Insights

Children have lower COVID-19 mortality than adults, with risk lowest between ages 3-10. COVID-19 deaths are significantly less common than other causes like pneumonia in children, especially the youngest.

Area of Science:

  • Pediatrics
  • Epidemiology
  • Infectious Diseases

Background:

  • Children generally exhibit better protection against COVID-19 compared to adults.
  • Limited understanding exists regarding pediatric COVID-19 susceptibility patterns and comparative disease risk.

Purpose of the Study:

  • To define COVID-19 mortality patterns in children.
  • To compare pediatric COVID-19 risk relative to other diseases and age-specific all-cause mortality.

Main Methods:

  • Analysis of COVID-19 mortality rates across different pediatric age groups.
  • Comparison of COVID-19 mortality with all-cause mortality and mortality from other infectious diseases (e.g., pneumonia, influenza).

Main Results:

  • COVID-19 mortality exhibits a U-shaped curve in childhood, decreasing to a minimum at ages 3-10 years, then increasing with age.
  • Childhood COVID-19 mortality rates are substantially lower than those for other diseases, with the greatest relative protection observed in the youngest children.
  • The proportion of COVID-19 deaths among all-cause deaths increases with age throughout childhood and adulthood.

Conclusions:

  • Children, particularly the youngest, experience a lower mortality risk from COVID-19 compared to other diseases.
  • The findings highlight the need to consider age-specific risks and relative disease burdens when assessing COVID-19's impact on pediatric populations.

Related Concept Videos

Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
393
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
44
Life Tables01:22

Life Tables

A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
244
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
56
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
46
Life Histories01:29

Life Histories

Overview
21.0K